Light-Triggered Nanozymes Remodel the Tumor Hypoxic and Immunosuppressive Microenvironment for Ferroptosis-Enhanced Antitumor Immunity
Top Cited Papers
- 29 April 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (19) , 12261-12275
Abstract
Cancer immunotherapy holds significant promise for addressing diverse malignancies. Nevertheless, its efficacy remains constrained by the intricate tumor immunosuppressive microenvironment. Herein, a light-triggered nanozyme Fe-TCPP-R848-PEG (Fe-MOF-RP) was designed for remodeling the immunosuppressive microenvironment. The Fe-TCPP-MOFs were utilized not only as a core catalysis component against tumor destruction but also as a biocompatible delivery vector of an immunologic agonist, improving its long circulation and tumor enrichment. Concurrently, it catalyzes the decomposition of H2O2 within the tumor, yielding oxygen to augment photodynamic therapy. The induced ferroptosis, in synergy with photodynamic therapy, prompts the liberation of tumor-associated antigens from tumor cells inducing immunogenic cell death. Phototriggered on-demand release of R848 agonists stimulated the maturation of dendritic cells and reverted the tumor-promoting M2 phenotypes into adoptive M1 macrophages, which further reshaped the tumor immunosuppressive microenvironment. Notably, the nanozyme effectively restrains well-established tumors, such as B16F10 melanoma. Moreover, it demonstrates a distal tumor-inhibiting effect upon in situ light treatment. What is more, in a lung metastasis model, it elicits robust immune memory, conferring enduring protection against tumor rechallenge. Our study presents a straightforward and broadly applicable strategy for crafting nanozymes with the potential to effectively thwart cancer recurrence and metastasis.Keywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515011664)
- Guangzhou Science, Technology and Innovation Commission (202201020438)
- National Natural Science Foundation of China (82002253, 82102083)
- Guangdong Province (A2021033)
- First Affiliated Hospital of Guangzhou Medical University (ZH202108)
This publication has 58 references indexed in Scilit:
- Nanodrugs with intrinsic radioprotective exertion: Turning the double‐edged sword into a single‐edged knifeExploration, 2023
- Tracking tumor heterogeneity and progression with near‐infrared II fluorophoresExploration, 2023
- Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate ImmunotherapyAdvanced Materials, 2022
- A Versatile 980 nm Absorbing Aggregation‐Induced Emission Luminogen for NIR‐II Imaging‐Guided Synergistic Photo‐Immunotherapy Against Advanced Pancreatic CancerAdvanced Functional Materials, 2022
- Multimodal Imaging‐Guided Photothermal Immunotherapy Based on a Versatile NIR‐II Aggregation‐Induced Emission LuminogenAngewandte Chemie International Edition, 2022
- Anti‐PD‐L1 DNAzyme Loaded Photothermal Mn2+/Fe3+ Hybrid Metal‐Phenolic Networks for Cyclically Amplified Tumor Ferroptosis‐ImmunotherapyAdvanced Healthcare Materials, 2021
- Conquering the Hypoxia Limitation for Photodynamic TherapyAdvanced Materials, 2021
- Nanozyme for tumor therapy: Surface modification mattersExploration, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged NanoparticlesAdvanced Functional Materials, 2020